Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Effect of smoking and time on cognitive function in the elderly without dementia.

Reitz C, Luchsinger J, Tang MX, Mayeux R.

Neurology. 2005 Sep 27;65(6):870-5.

2.

Stroke and memory performance in elderly persons without dementia.

Reitz C, Luchsinger JA, Tang MX, Manly J, Mayeux R.

Arch Neurol. 2006 Apr;63(4):571-6.

3.

Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

Mayeux R, Small SA, Tang M, Tycko B, Stern Y.

Neurobiol Aging. 2001 Jul-Aug;22(4):683-9.

PMID:
11445269
4.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
5.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
6.

APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.

Klages JD, Fisk JD, Rockwood K.

Dement Geriatr Cogn Disord. 2003;15(1):1-5.

PMID:
12457072
7.

Alcohol consumption and cognitive function in late life: a longitudinal community study.

Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH.

Neurology. 2005 Oct 25;65(8):1210-7.

PMID:
16247047
9.

APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.

Schiepers OJ, Harris SE, Gow AJ, Pattie A, Brett CE, Starr JM, Deary IJ.

Mol Psychiatry. 2012 Mar;17(3):315-24. doi: 10.1038/mp.2010.137. Epub 2011 Jan 25.

PMID:
21263443
10.

Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Reitz C, Luchsinger J, Tang MX, Manly J, Mayeux R.

Neurology. 2005 Apr 26;64(8):1378-83.

11.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
12.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
13.

APOE genotype and cognitive decline in a middle-aged cohort.

Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E; Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Neurology. 2005 Jan 25;64(2):268-76.

PMID:
15668424
14.

Substantial effects of apolipoprotein E ε4 on memory decline in very old age: longitudinal findings from a population-based sample.

Praetorius M, Thorvaldsson V, Hassing LB, Johansson B.

Neurobiol Aging. 2013 Dec;34(12):2734-9. doi: 10.1016/j.neurobiolaging.2013.06.002. Epub 2013 Jul 12.

PMID:
23855979
15.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
16.

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

Son SJ, Lee KS, Lee Y, Baek JH, Choi SH, Na DL, Seo SW, Oh BH, Hong CH.

J Clin Psychiatry. 2012 Dec;73(12):1555-62. doi: 10.4088/JCP.12m07702. Epub 2012 Oct 30.

PMID:
23146133
17.

Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.

Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG.

Neurology. 2004 Jun 8;62(11):1990-5.

PMID:
15184602
18.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
19.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
20.

The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.

Carmelli D, DeCarli C, Swan GE, Kelly-Hayes M, Wolf PA, Reed T, Guralnik JM.

J Gerontol A Biol Sci Med Sci. 2000 Feb;55(2):M103-9.

PMID:
10737693
Items per page

Supplemental Content

Write to the Help Desk